Chronic Obstructive Pulmonary Diseases:Journal of the COPD Foundation

Articles in Press

Peer-reviewed, accepted articles are posted in Articles in Press shortly after editorial acceptance. These posted articles (below) have completed a rigorous peer review process but the articles have NOT been copyedited or designed. Copyedited, designed, final versions of these articles will be created and published in a Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation (JCOPDF) upcoming issue. Articles in Press citations/abstracts are submitted to PubMed.

To receive notifications of the posting of new Articles in Press AND the posting of new JCOPDF issues, sign up for a FREE SUBSCRIPTION HERE.


Interpreting Evaluating Respiratory Symptoms in COPD Diary Scores in Clinical Trials: Terminology, Methods, and Recommendations

Nancy Kline Leidy1 Donald M. Bushnell1 Chau Thach2 Carolina Hache2 Florian S. Gutzwiller2

Citation: Leidy NK, Bushnell DM, Thach C, Hache C, Gutzwiller FS. Interpreting E-RS:COPD scores in clinical trials: terminology, methods, and recommendations. Chronic Obstr Pulm Dis. 2022; Published online September 21, 2022. doi: https://doi.org/10.15326/jcopdf.2022.0307


Patient-Reported Pulmonary Symptoms, Exacerbations, and Management in a Cohort of Patients With Alpha-1 Antitrypsin Deficiency

Radmila Choate, PhD, MPH1 Robert A. Sandhaus, MD, PhD2,3 Kristen E. Holm, PhD, MPH2,3 David M. Mannino MD4 Charlie Strange, MD3,5

Citation: Choate R, Sandhaus RA, Holm KE, Mannino DM, Strange C. Patient-reported pulmonary symptoms, exacerbations, and management in a cohort of patients with alpha-1 antitrypsin deficiency. Chronic Obstr Pulm Dis. 2022; Published online September 14, 2022. doi: https://doi.org/10.15326/jcopdf.2022.0317


Endurance Time During Constant Work Rate Cycle Ergometry in COPD: Development of an Integrated Database From Interventional Studies

Richard Casaburi, PhD, MD1 Debora Merrill, MBA2 Thomas Dolmage, MSc3 Judith Garcia-Aymerich, MD, PhD4,5,6 Malin Fageras, PhD7 Roger Goldstein, MD8 Gale Harding, MS9 Nancy Kline Leidy, PhD9 François Maltais, MD10 Denis O’Donnell, MD11 Janos Porszasz, MD, PhD1 Luis Puente-Maestu, PhD, MD12,13 Stephen Rennard, MD14 Frank Sciurba, MD15 Martijn A. Spruit, PhD, PT16 Ruth Tal-Singer, PhD2 Kay Tetzlaff, MD17,18 Alex van’t Hul, PhD19 Ren Yu, MA9 Alan Hamilton, PhD2

Citation: Casaburi R, Merrill D, Dolmage T, et al. endurance time during constant work rate cycle ergometry in COPD: development of an integrated database from interventional studies. Chronic Obstr Pulm Dis. 2022; Published online August 31, 2022. doi: https://doi.org/10.15326/jcopdf.2022.0331


Beyond Access: Factors Associated with Spirometry Underutilization Among Patients With a Diagnosis of COPD in Urban Tertiary Care Centers

Arianne K. Baldomero, MD MS1,23 Ken M. Kunisaki, MD MS1,2 Ann Bangerter, BS3 David B. Nelson, PhD3 Chris H. Wendt, MD1,2 Spyridon Fortis4,5 Hildi Hagedorn, PhD3 R. Adams Dudley, MD MBA1,23

Citation: Baldomero AK, Kunisaki KM, Bangerter A, et al. Beyond access: factors associated with spirometry underutilization among patients with a diagnosis of COPD in urban tertiary care centers. Chronic Obstr Pulm Dis. 2022; Published online August 30, 2022. doi: https://doi.org/10.15326/jcopdf.2022.0303


Impact of the Coronavirus Disease 2019 Pandemic on Physical and Mental Health of Patients With COPD: Results From a Longitudinal Cohort Study Conducted in the United States (2020-2021)

William Z. Zhang1* Stephanie L. LaBedz2* Janet T. Holbrook3 Andrew Gangemi4 Ramasubramanian Baalachandran5 Michelle N. Eakin6 Robert A. Wise6 Kaharu Sumino7 for the American Lung Association Airways Clinical Research Centers

Citation: Zhang WZ, LaBedz SL, Holbrook JT, et al. Impact of the coronavirus disease 2019 pandemic on physical and mental health of patients with COPD: results from a longitudinal cohort study conducted in the United States (2020-2021). Chronic Obstr Pulm Dis. 2022; Published online August 23, 2022. doi: https://doi.org/10.15326/jcopdf.2022.0287


Antibody Response to SARS-CoV-2 Vaccination in COPD: A Cohort Study

Éliane Pelletier1,2, Philippe Desmeules3, Yves Lacasse1,2, Sophie Tanguay1,2, Julie Milot1,2, Mathieu C Morissette1,2, François Maltais1,2

Citation: Pelletier E, Desmeules P, Lacasse Y, et al. Antibody response to SARS-CoV-2 vaccination in COPD: a cohort study. Chronic Obstr Pulm Dis. 2022; Published online August 3, 2022. doi: https://doi.org/10.15326/jcopdf.2022.0315


The Effect of Rurality and Poverty on COPD Outcomes in New Hampshire: an Analysis of Statewide Hospital Discharge Data

Jacob S. Warner, DO1 Jane M. Bryan2 Laura M. Paulin, MD3

Citation: Warner JS, Bryan JM, Paulin LM. The effect of rurality and poverty on COPD outcomes in New Hampshire: an analysis of statewide hospital discharge data. Chronic Obstr Pulm Dis. 2022; Published online July 29, 2022. doi: https://doi.org/10.15326/jcopdf.2022.0299


Varenicline for Gradual Versus Abrupt Smoking Cessation in Poorly Motivated Smokers With COPD: A Prematurely Terminated Randomized Controlled Trial

Abraham Bohadana, MD1 Ariel Rokach, MD1 Pascal Wild, PhD2 Bela Peker1 Yossi-Freier Dror, PhD3 Polina Babai3 Nissim Arish,MD1 Gabriel Izbicki, MD1

Citation: Bohadana A, Rokach A, Wild P, et al. Varenicline for gradual versus abrupt smoking cessation in poorly motivated smokers with COPD: a prematurely terminated randomized controlled trial. Chronic Obstr Pulm Dis. 2022; Published online July 22, 2022. doi: https://doi.org/10.15326/jcopdf.2022.0305